BIO — Biotest Gmbh and Co. KgaA Share Price
0.000.00%
Last trade - 00:00- €1.54bn
- €2.27bn
- €648.90m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.33 | ||
| Price to Tang. Book | 3.45 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.38 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -3.73% | ||
| Return on Equity | -14.22% | ||
| Operating Margin | -7.91% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 515.6 | 516.1 | 684.6 | 726.2 | 648.9 | n/a | n/a | 6.03% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +241.88 | -82.5 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biotest Gmbh and Co. KgaA, formerly known as Biotest AG, is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. It develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
Directors
- Rolf Hoffmann CSU (62)
- Michael Ramroth CMG (59)
- Tan Yang VSU
- Martin Moeller FID
- Georg Floss COO (59)
- Oliver Hein CCO
- Stephan Fleck CTR
- Enrico D'aiuto DSL
- Christina Erb DHR
- Josefine Buth OTH
- Roland Gross OTH
- Michael Moritz OTH
- Christian Polus OTH
- Martin Reinecke OTH
- Peter Seith OTH
- Kerstin Birkhahn SUB
- Simone Fischer SUB
- Xiaoying Gao SUB
- Juergen Heilmann SUB
- Last Annual
- December 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- July 31st, 2006
- Public Since
- October 14th, 1987
- No. of Employees
- 2,698
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Hamburg Stock Exchange
- Shares in Issue
- 39,571,452
- Address
- Landsteinerstr. 5, DREIEICH, 63303
- Web
- https://www.biotest.com
- Phone
- +49 61038010
- Auditors
- Deloitte GmbH Wirtschaftsprufungsgesellschaft
Upcoming Events for BIO
Dividend For BIOG_p.H - 0.0400 EUR
Similar to BIO
Haemato AG
Hamburg Stock Exchange
MediNavi AG
Hamburg Stock Exchange
FAQ
What is the Biotest Gmbh and Co. KgaA share price?
As of Today at 19:38 UTC, shares in Biotest Gmbh and Co. KgaA are trading at €39.00. This share price information is delayed by 15 minutes.
How has the Biotest Gmbh and Co. KgaA share price performed this year?
Shares in Biotest Gmbh and Co. KgaA last closed at €39.00 and the price had moved by -6.7% over the past 365 days. In terms of relative price strength the Biotest Gmbh and Co. KgaA share price has underperformed the FTSE Global All Cap Index by -18.42% over the past year.
What are the analyst and broker recommendations for Biotest Gmbh and Co. KgaA?
There is no consensus recommendation for this security.
Find out moreWhat is the Biotest Gmbh and Co. KgaA dividend yield?
Biotest Gmbh and Co. KgaA does not currently pay a dividend.
Does Biotest Gmbh and Co. KgaA pay a dividend?
Biotest Gmbh and Co. KgaA does not currently pay a dividend.
When does Biotest Gmbh and Co. KgaA next pay dividends?
Biotest Gmbh and Co. KgaA does not currently pay a dividend.
How do I buy Biotest Gmbh and Co. KgaA shares?
To buy shares in Biotest Gmbh and Co. KgaA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Biotest Gmbh and Co. KgaA?
As of the previous close price of €39.00, shares in Biotest Gmbh and Co. KgaA had a market capitalisation of €1.54bn.
Where are Biotest Gmbh and Co. KgaA shares listed?
Here are the trading details for Biotest Gmbh and Co. KgaA:
- Country of listing: Germany
- Exchange: HAM
- Ticker Symbol: BIO
What kind of share is Biotest Gmbh and Co. KgaA?
Based on an overall assessment of its quality, value and momentum Biotest Gmbh and Co. KgaA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Biotest Gmbh and Co. KgaA share price forecast for 2026?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Biotest Gmbh and Co. KgaA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biotest Gmbh and Co. KgaA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -3.94%.
As of the last closing price of €39.00, shares in Biotest Gmbh and Co. KgaA were trading +1.76% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Biotest Gmbh and Co. KgaA PE Ratio?
The Biotest Gmbh and Co. KgaA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €39.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Biotest Gmbh and Co. KgaA?
Biotest Gmbh and Co. KgaA's management team is headed by:
- Rolf Hoffmann - CSU
- Michael Ramroth - CMG
- Tan Yang - VSU
- Martin Moeller - FID
- Georg Floss - COO
- Oliver Hein - CCO
- Stephan Fleck - CTR
- Enrico D'aiuto - DSL
- Christina Erb - DHR
- Josefine Buth - OTH
- Roland Gross - OTH
- Michael Moritz - OTH
- Christian Polus - OTH
- Martin Reinecke - OTH
- Peter Seith - OTH
- Kerstin Birkhahn - SUB
- Simone Fischer - SUB
- Xiaoying Gao - SUB
- Juergen Heilmann - SUB